ibrutinib,venetoclax,Obinutuzumab
roche,janssen,abbvie,biogen
['ibru', 'congrat', 'cll']
very interesting data from the randomized cll13 trial cit vs vg vs vr vs vg+ibru in 1l young fit cll pts. fcr in ighv-mutated still seems to hold up! extremely important data. congrats to barbara eichhorst, dcllsg and all the investigators! #cll
Hematologist at https://t.co/5Cv9rH6CW0; CLL expert. Professor at https://t.co/iQLiqw0Vhp. Evidence-based medicine. Trumpet / chess / golf player. Tweets are solely my personal views.